Ventyx Biosciences Inc (VTYX) Ends at $13.86 on Thursday

Kevin Freeman

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.21 million shares were traded. VTYX stock price reached its highest trading level at $13.88 during the session, while it also had its lowest trading level at $13.84.

Ratios:

Our goal is to gain a better understanding of VTYX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.86 and its Current Ratio is at 17.86. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.

On March 12, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $7 to $16.

Oppenheimer Upgraded its Perform to Outperform on March 12, 2024, while the target price for the stock was maintained at $12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 18 ’25 when Mohan Raju sold 47,345 shares for $7.72 per share. The transaction valued at 365,461 led to the insider holds 2,372,863 shares of the business.

Nuss John sold 12,675 shares of VTYX for $97,840 on Dec 18 ’25. The CHIEF SCIENTIFIC OFFICER now owns 489,481 shares after completing the transaction at $7.72 per share. On Dec 18 ’25, another insider, Nuss John, who serves as the Officer of the company, bought 12,675 shares for $7.72 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 994456960 and an Enterprise Value of 806416704.

Stock Price History:

The Beta on a monthly basis for VTYX is 1.25, which has changed by 5.8613863 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, VTYX has reached a high of $25.00, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 43.68%, while the 200-Day Moving Average is calculated to be 218.24%.

Shares Statistics:

The stock has traded on average 5.67M shares per day over the past 3-months and 9955590 shares per day over the last 10 days, according to various share statistics. A total of 71.34M shares are outstanding, with a floating share count of 64.33M. Insiders hold about 10.34% of the company’s shares, while institutions hold 61.57% stake in the company. Shares short for VTYX as of 1767139200 were 7294699 with a Short Ratio of 1.29, compared to 1764288000 on 5424203. Therefore, it implies a Short% of Shares Outstanding of 7294699 and a Short% of Float of 10.86.

Earnings Estimates

Investors are keenly observing as 7.0 analysts analyze and rate. The current performance of Ventyx Biosciences Inc (VTYX) in the stock market.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.27 and low estimates of -$0.51.

Analysts are recommending an EPS of between -$1.35 and -$1.57 for the fiscal current year, implying an average EPS of -$1.44. EPS for the following year is -$1.63, with 7.0 analysts recommending between -$1.14 and -$2.1.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.